Formulation and numerical simulations of a continuum model of avascular tumor growth.

Math Biosci

Department of Applied Mathematics, Mechanical Engineering Faculty, University of Žilina, 010 26 Žilina, Slovakia.

Published: June 2011

In this paper we present a continuum mathematical model for a multicellular spheroid that mimics the micro-environment within avascular tumor growth. The model consists of a coupled system of non-linear convection-diffusion-reaction equations. This system is solved using a previously developed conservative Galerkin characteristics method. In the model considered, there are three cell types: the proliferative cells, the quiescent non-dividing cells which stay in the G(0) phase of the cell cycle and the necrotic cells. The model includes viable cell diffusion, diffusion of cellular material and the removal of necrotic cells. We assume that the nutrients diffuse passively and are consumed by the proliferative and quiescent tumor cells depending on the availability of resources (oxygen, glucose, etc.). The numerical simulations are performed using different sets of parameters, including biologically realistic ones, to explore the effects of each of these model parameters on reaching the steady state. The present results, taken together with those reported earlier, indicate that the removal of necrotic cells and the diffusion of cellular material have significant effects on the steady state, reflecting growth saturation, the number of viable cells, and the spheroid size.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mbs.2011.03.002DOI Listing

Publication Analysis

Top Keywords

necrotic cells
12
numerical simulations
8
avascular tumor
8
tumor growth
8
diffusion cellular
8
cellular material
8
removal necrotic
8
steady state
8
cells
7
model
6

Similar Publications

Minimal change disease (MCD) accounts for 10 - 15% of idiopathic nephrotic syndromes in adults. Chronic hepatitis C virus (HCV) infection is rarely ascribed as a cause of MCD and was previously associated with interferon-based therapy. MCD in treatment-naïve chronic HCV infection is extremely rare, with only 3 cases reported in the literature.

View Article and Find Full Text PDF

Construction of a prognostic survival model with tumor immune-related genes for breast cancer.

Transl Cancer Res

December 2024

Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.

Background: Numerous studies have demonstrated that immune cell infiltration is a significant predictor in the prognosis of those with breast cancer. This study aimed to develop a prognostic model for undifferentiated breast cancer using immune-related markers.

Methods: Differentially expressed genes (DEGs) and prognostic factors were identified from The Cancer Genome Atlas (TCGA) database.

View Article and Find Full Text PDF

Background: Speckle-type POZ protein (SPOP), FAS-associated protein with death domain (FADD), and nuclear transcription factor-κB (NF-κB) have been shown to be associated with the development of prostate cancer (PCa). FADD has been shown to activate the NF-κB pathway to promote tumorigenesis, while SPOP has been shown to enhance the breakdown of FADD and inhibit the function of the NF-κB signaling pathway in non-small cell lung cancer. The existence of this mechanism has not yet been confirmed in PCa.

View Article and Find Full Text PDF

HUVECs-derived exosomes increase neovascularization and decrease limb necrosis in hindlimb ischemia.

Narra J

December 2024

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Chronic limb-threatening ischemia (CLTI) is the most severe manifestation of peripheral arterial disease (PAD) and imposes a significantly high burden due to its high risk of mortality and amputation. Revascularization is the first-line treatment for CLTI; however, the amputation rate remains high, and approximately one-third of patients are not eligible for this treatment. Therefore, there is an urgent need for more effective therapeutic strategies.

View Article and Find Full Text PDF

Ischemic stroke is a sudden onset of neurological deficit resulting from a blockage in cerebral blood vessels, which can lead to brain tissue damage, chronic disability, and increased risk of mortality. Secretome from hypoxic mesenchymal stem cells (SH-MSC) is a potential therapy to improve neurological deficit by increasing the expression of vascular endothelial growth factor (VEGF) and reducing glial fibrillary acidic protein (GFAP). These effects can reduce the infarction area of ischemic stroke.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!